148 related articles for article (PubMed ID: 25368103)
1. Non-randomized confirmatory trial of modified radical hysterectomy for patients with tumor diameter 2 cm or less FIGO Stage IB1 uterine cervical cancer: Japan Clinical Oncology Group Study (JCOG1101).
Kunieda F; Kasamatsu T; Arimoto T; Onda T; Toita T; Shibata T; Fukuda H; Kamura T;
Jpn J Clin Oncol; 2015 Jan; 45(1):123-6. PubMed ID: 25368103
[TBL] [Abstract][Full Text] [Related]
2. Clinical tumor diameter and prognosis of patients with FIGO stage IB1 cervical cancer (JCOG0806-A).
Kato T; Takashima A; Kasamatsu T; Nakamura K; Mizusawa J; Nakanishi T; Takeshima N; Kamiura S; Onda T; Sumi T; Takano M; Nakai H; Saito T; Fujiwara K; Yokoyama M; Itamochi H; Takehara K; Yokota H; Mizunoe T; Takeda S; Sonoda K; Shiozawa T; Kawabata T; Honma S; Fukuda H; Yaegashi N; Yoshikawa H; Konishi I; Kamura T;
Gynecol Oncol; 2015 Apr; 137(1):34-9. PubMed ID: 25662625
[TBL] [Abstract][Full Text] [Related]
3. Comparison of laparoscopic versus abdominal radical hysterectomy for FIGO stage IB and IIA cervical cancer with tumor diameter of 3 cm or greater.
Kong TW; Chang SJ; Lee J; Paek J; Ryu HS
Int J Gynecol Cancer; 2014 Feb; 24(2):280-8. PubMed ID: 24407571
[TBL] [Abstract][Full Text] [Related]
4. Radical hysterectomy compared with primary radiation for treatment of stage IB1 cervix cancer.
Doll KM; Donnelly E; Helenowski I; Rosenbloom L; Small W; Schink JC; Lurain JR
Am J Clin Oncol; 2014 Feb; 37(1):30-4. PubMed ID: 22992622
[TBL] [Abstract][Full Text] [Related]
5. Identifying selection criteria for non-radical hysterectomy in FIGO stage IB cervical cancer.
Kasamatsu T; Ishikawa M; Murakami N; Okada S; Ikeda SI; Kato T; Itami J
J Obstet Gynaecol Res; 2019 Apr; 45(4):882-891. PubMed ID: 30672089
[TBL] [Abstract][Full Text] [Related]
6. Early stage cervical cancer: Brachytherapy followed by type a hysterectomy versus type B radical hysterectomy alone, a retrospective evaluation.
Lacorre A; Merlot B; Garabedian C; Narducci F; Chereau E; Resbeut M; Minsat M; Leblanc E; Houvenaeghel G; Lambaudie E
Eur J Surg Oncol; 2016 Mar; 42(3):376-82. PubMed ID: 26725307
[TBL] [Abstract][Full Text] [Related]
7. Do FIGO stage IA and small (≤2 cm) IB1 cervical adenocarcinomas have a good prognosis and warrant less radical surgery?
Al-Kalbani M; McVeigh G; Nagar H; McCluggage WG
Int J Gynecol Cancer; 2012 Feb; 22(2):291-5. PubMed ID: 22080884
[TBL] [Abstract][Full Text] [Related]
8. Radical hysterectomy for FIGO stage IIB cervical cancer: clinicopathological characteristics and prognostic evaluation.
Kasamatsu T; Onda T; Sawada M; Kato T; Ikeda S
Gynecol Oncol; 2009 Jul; 114(1):69-74. PubMed ID: 19398126
[TBL] [Abstract][Full Text] [Related]
9. SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancer.
Chiva L; Zanagnolo V; Querleu D; Martin-Calvo N; Arévalo-Serrano J; Căpîlna ME; Fagotti A; Kucukmetin A; Mom C; Chakalova G; Aliyev S; Malzoni M; Narducci F; Arencibia O; Raspagliesi F; Toptas T; Cibula D; Kaidarova D; Meydanli MM; Tavares M; Golub D; Perrone AM; Poka R; Tsolakidis D; Vujić G; Jedryka MA; Zusterzeel PLM; Beltman JJ; Goffin F; Haidopoulos D; Haller H; Jach R; Yezhova I; Berlev I; Bernardino M; Bharathan R; Lanner M; Maenpaa MM; Sukhin V; Feron JG; Fruscio R; Kukk K; Ponce J; Minguez JA; Vázquez-Vicente D; Castellanos T; Chacon E; Alcazar JL;
Int J Gynecol Cancer; 2020 Sep; 30(9):1269-1277. PubMed ID: 32788262
[TBL] [Abstract][Full Text] [Related]
10. Oncologic results and surgical morbidity of laparoscopic nerve-sparing radical hysterectomy in the treatment of FIGO stage IB cervical cancer: long-term follow-up.
Park NY; Chong GO; Hong DG; Cho YL; Park IS; Lee YS
Int J Gynecol Cancer; 2011 Feb; 21(2):355-62. PubMed ID: 21270616
[TBL] [Abstract][Full Text] [Related]
11. Single-arm confirmatory trial of postoperative concurrent chemoradiotherapy using intensity modulated radiation therapy for patients with high-risk uterine cervical cancer: Japan Clinical Oncology Group study (JCOG1402).
Murakami N; Isohashi F; Hasumi Y; Kasamatsu T; Okamoto H; Nakamura K; Shibata T; Ito Y; Ishikura S; Nishimura Y; Yaegashi N; Toita T
Jpn J Clin Oncol; 2019 Sep; 49(9):881-885. PubMed ID: 31613355
[TBL] [Abstract][Full Text] [Related]
12. Parametrial involvement in FIGO stage IB1 cervical carcinoma diagnostic impact of tumor diameter in preoperative magnetic resonance imaging.
Kamimori T; Sakamoto K; Fujiwara K; Umayahara K; Sugiyama Y; Utsugi K; Takeshima N; Tanaka H; Gomi N; Takizawa K
Int J Gynecol Cancer; 2011 Feb; 21(2):349-54. PubMed ID: 21721193
[TBL] [Abstract][Full Text] [Related]
13. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
Rutledge TL; Kamelle SA; Tillmanns TD; Gould NS; Wright JD; Cohn DE; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112
[TBL] [Abstract][Full Text] [Related]
14. Class I versus class III radical hysterectomy in stage IB1-IIA cervical cancer. A prospective randomized study.
Landoni F; Maneo A; Zapardiel I; Zanagnolo V; Mangioni C
Eur J Surg Oncol; 2012 Mar; 38(3):203-9. PubMed ID: 22244909
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the effect of adjuvant radiotherapy on outcomes and complications after radical hysterectomy in FIGO stage IB1 cervical cancer patients with intermediate risk factors (GOTIC Study).
Nakamura K; Kitahara Y; Satoh T; Takei Y; Takano M; Nagao S; Sekiguchi I; Suzuki M
World J Surg Oncol; 2016 Jun; 14(1):173. PubMed ID: 27356862
[TBL] [Abstract][Full Text] [Related]
16. Postoperative outcomes of MR-invisible stage IB1 cervical cancer.
Park JY; Lee JW; Park BK; Lee YY; Choi CH; Kim TJ; Bae DS; Kim BG; Park JJ; Park SY; Kim CK
Am J Obstet Gynecol; 2014 Aug; 211(2):168.e1-7. PubMed ID: 24607752
[TBL] [Abstract][Full Text] [Related]
17. Total laparoscopic versus open radical hysterectomy in stage IA2-IB1 cervical cancer: disease recurrence and survival comparison.
Toptas T; Simsek T
J Laparoendosc Adv Surg Tech A; 2014 Jun; 24(6):373-8. PubMed ID: 24742012
[TBL] [Abstract][Full Text] [Related]
18. A model for prediction of parametrial involvement and feasibility of less radical resection of parametrium in patients with FIGO stage IB1 cervical cancer.
Chang SJ; Bristow RE; Ryu HS
Gynecol Oncol; 2012 Jul; 126(1):82-6. PubMed ID: 22516661
[TBL] [Abstract][Full Text] [Related]
19. A phase III randomized clinical trial comparing laparoscopic or robotic radical hysterectomy with abdominal radical hysterectomy in patients with early stage cervical cancer.
Obermair A; Gebski V; Frumovitz M; Soliman PT; Schmeler KM; Levenback C; Ramirez PT
J Minim Invasive Gynecol; 2008; 15(5):584-8. PubMed ID: 18722970
[TBL] [Abstract][Full Text] [Related]
20. Effect of transcutaneous electrical stimulation treatment on lower urinary tract symptoms after class III radical hysterectomy in cervical cancer patients: study protocol for a multicentre, randomized controlled trial.
Sun XL; Wang HB; Wang ZQ; Cao TT; Yang X; Han JS; Wu YF; Reilly KH; Wang JL
BMC Cancer; 2017 Jun; 17(1):416. PubMed ID: 28619043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
